Inhibition of the MAPK pathway in both BRAF-mutant and wild type melanoma cells resulted in increased expression of melanocytes-differentiation antigens which is associated with improved recognition by antigen-specific T lymphocytes 31, 32. The gene discussed is BRAF; the disease is melanoma.